NAS
KURA icon

Nykredit A/S’s Kura Oncology KURA Stock Holding History

Nykredit A/S’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3K Buy
+1,026
New +$9.68K ﹤0.01% 1854

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nykredit A/S's KURA Position: Q2 2026 in Review

Nykredit A/S opened a new position in Kura Oncology (KURA) in Q2 2026: 1,026 shares worth $11.3K. The stake represents ﹤0.01% of the portfolio and ranks #1854 among its holdings.

146 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Nykredit A/S held 1,026 shares of Kura Oncology worth $11.3K as of Q2 2026.
  • Kura Oncology was a new Nykredit A/S position in Q2 2026.
  • Kura Oncology made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #1854 holding.
  • 146 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.